Molecular age estimation based on posttranslational protein modifications in bone: why the type of bone matters.


Journal

International journal of legal medicine
ISSN: 1437-1596
Titre abrégé: Int J Legal Med
Pays: Germany
ID NLM: 9101456

Informations de publication

Date de publication:
Mar 2023
Historique:
received: 21 09 2022
accepted: 09 01 2023
pubmed: 18 1 2023
medline: 9 2 2023
entrez: 17 1 2023
Statut: ppublish

Résumé

Age-at-death estimation is of great relevance for the identification of unknown deceased individuals. In skeletonised corpses, teeth and bones are theoretically available for age estimation, but in many cases, only single bones or even only bone fragments are available for examination. In these cases, conventional morphological methods may not be applicable, and the application of molecular methods may be considered. Protein-based molecular methods based on the D-aspartic acid (D-Asp) or pentosidine (Pen) content have already been successfully applied to bone samples. However, the impact of the analysed type of bone has not yet been systematically investigated, and it is still unclear whether data from samples of one skeletal region (e.g. skull) can also be used for age estimation for samples of other regions (e.g. femur). To address this question, D-Asp and Pen were analysed in bone samples from three skeletal regions (skull, clavicle, and rib), each from the same individual. Differences between the bone types were tested by t-test, and correlation coefficients (ρ) were calculated according to Spearman. In all types of bone, an age-dependent accumulation of D-Asp and Pen was observed. However, both parameters (D-Asp and Pen) exhibited significant differences between bone samples from different anatomical regions. These differences can be explained by differences in structure and metabolism in the examined bone types and have to be addressed in age estimation based on D-Asp and Pen. In future studies, bone type-specific training and test data have to be collected, and bone type-specific models have to be established.

Identifiants

pubmed: 36648544
doi: 10.1007/s00414-023-02948-9
pii: 10.1007/s00414-023-02948-9
pmc: PMC9902325
doi:

Substances chimiques

D-Aspartic Acid 4SR0Q8YD1X
Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

437-443

Informations de copyright

© 2023. The Author(s).

Références

Int J Legal Med. 2016 Jan;130(1):207-11
pubmed: 26303762
Int J Legal Med. 2018 May;132(3):799-805
pubmed: 28905104
Calcif Tissue Int. 2011 Jun;88(6):521-9
pubmed: 21499867
Int J Legal Med. 2018 Nov;132(6):1749-1758
pubmed: 30069788
Forensic Sci Int. 1996 Jan 12;77(1-2):13-26
pubmed: 8675133
Z Gerontol Geriatr. 2007 Oct;40(5):349-56
pubmed: 17943238
Forensic Sci Int. 1985 Nov-Dec;29(3-4):259-67
pubmed: 4076954
Int J Mol Sci. 2022 Mar 22;23(7):
pubmed: 35408796
Int J Legal Med. 2003 Apr;117(2):96-101
pubmed: 12690506
Arch Oral Biol. 2007 Mar;52(3):233-6
pubmed: 17097046
Forensic Sci Int. 2010 Dec 15;203(1-3):34-43
pubmed: 20702051
Int J Legal Med. 2010 Jul;124(4):269-75
pubmed: 19924428
Clin Biochem Rev. 2005 Nov;26(4):97-122
pubmed: 16648882
Sports Med. 2002;32(13):819-36
pubmed: 12392443
Ageing Res Rev. 2013 Mar;12(2):605-17
pubmed: 23454111
J Anat. 2022 Dec;241(6):1344-1356
pubmed: 36004686
J Appl Lab Med. 2020 May 1;5(3):558-568
pubmed: 32445362
J Forensic Sci. 1998 Sep;43(5):949-53
pubmed: 9729809
J Forensic Sci. 2021 Jul;66(4):1524-1532
pubmed: 33942892
Int J Mol Sci. 2020 May 23;21(10):
pubmed: 32456199
Biochem J. 2006 Oct 1;399(1):29-35
pubmed: 16787390
J Dent Res. 2010 Dec;89(12):1333-48
pubmed: 20924069
J Biol Chem. 1989 Apr 15;264(11):6164-70
pubmed: 2703484
Int J Legal Med. 2021 Jul;135(4):1225-1233
pubmed: 33595689
Biochem J. 2000 Sep 1;350 Pt 2:381-7
pubmed: 10947951
Curr Osteoporos Rep. 2006 Sep;4(3):103-9
pubmed: 16907999
J Biol Chem. 1987 Jan 15;262(2):785-94
pubmed: 3805008
Int J Legal Med. 2003 Jun;117(3):149-52
pubmed: 12684820
Ageing Res Rev. 2002 Feb;1(1):43-59
pubmed: 12039448
J Sci Food Agric. 2018 Jul;98(9):3225-3233
pubmed: 29280151
Recent Prog Horm Res. 2001;56:1-21
pubmed: 11237208
Int J Legal Med. 2020 Mar;134(2):721-733
pubmed: 30976985
Indian J Endocrinol Metab. 2016 Nov-Dec;20(6):846-852
pubmed: 27867890
Forensic Sci Int. 1994 Dec 1;69(2):149-59
pubmed: 7813998

Auteurs

Lisa König (L)

Institute of Legal Medicine, University Hospital Düsseldorf, 40225, Düsseldorf, Germany. lisa.koenig@med.uni-duesseldorf.de.

Julia Becker (J)

Institute of Legal Medicine, University Hospital Düsseldorf, 40225, Düsseldorf, Germany.

Alexandra Reckert (A)

Institute of Legal Medicine, University Hospital Düsseldorf, 40225, Düsseldorf, Germany.

Stefanie Ritz-Timme (S)

Institute of Legal Medicine, University Hospital Düsseldorf, 40225, Düsseldorf, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH